Leveraging Diagnostic Development to Protect Against RSV, Flu, and Covid-19

During the initial phase of the Covid-19 pandemic, healthcare professionals were dedicated to understanding the virus, developing preventative measures, and creating tests for detection. They worked diligently to collect and analyze health data to monitor the public health threat at different levels. As time passed, the focus shifted towards vaccine development and distribution to slow the spread of the virus and minimize its impact on the population.

Recently, there has been concern about the convergence of Covid-19 with other viruses such as the flu, RSV, and Group A Strep. The simultaneous presence of these viruses has put immense pressure on hospitals that are already understaffed and struggling to cope with the aftermath of the pandemic. In response to this challenge, the FDA has granted Emergency Use Authorization to the BD MAX Molecular Diagnostic System for detecting SARS-CoV-2, influenza A + B, and RSV.

To address this evolving situation, BD is organizing a webinar on March 7 to explore the implications of different viruses coexisting in the current environment. The webinar will delve into the potential risks posed by the convergence of these viruses, the symptoms and clinical presentation, and the impact on children. Additionally, it will highlight the benefits of the BD Veritorâ„¢ Plus System and the innovative measures taken by companies like BD to support public health.

Key discussion points of the webinar will include an overview of recent respiratory seasons, the clinical implications of RSV, flu, and other respiratory diseases, and the advancements in diagnostic tools such as the BD Veritorâ„¢ Plus System. Participants will have the opportunity to learn how diagnostic development can help mitigate the risks associated with the coexistence of multiple viruses. To register for the webinar titled "How to leverage diagnostic development to guard against the perfect storm of viruses," interested individuals can fill out the form provided above.